Spotlight on growth

With many industry sectors seeing margins slide simultaneously, players across the industry are playing defense to prevent further erosion in profitability. Insurers are dialing up denials and rightsizing their portfolios, health systems are doubling down on revenue cycle performance and looking for opportunities to reduce both clinical and non-clinical labor costs, and life sciences companies are looking to technology to reduce R&D costs. But that doesn’t mean that aren’t still pockets of growth across the industry. Join us as we discuss strategic opportunities and challenges in three fast-moving innovation and investment areas: Cancer care, agentic AI, and GLP-1s​.